Port Saint Lucie Hospital
-
Services:
- Private for-profit organization
- Male
- Female
- Benzodiazepines Detoxification
- Opioids detoxification
- Medication routinely used during detoxification
- Alcohol Detoxification
- Buprenorphine used in Treatment
- Naltrexone used in Treatment
- Criminal justice (other than DUI/DWI)/Forensic clients
- Clients who have experienced intimate partner violence, domestic violence
- Veterans
- Clients who have experienced trauma
- Young adults
- Adult women
- Adult men
- Clients with co-occurring mental and substance use disorders
- Members of military families
- Clients who have experienced sexual abuse
- Seniors or older adults
- Active duty military
- Clients with HIV or AIDS
- Lesbian, gay, bisexual, transgender, or queer/questioning (LGBTQ)
- Detoxification
- Substance use treatment
- Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
- Medicare
- Private health insurance
- Cash or self-payment
- Medicaid
- Federal military insurance (e.g., TRICARE)
- Substance use disorder counseling
- Relapse prevention
- 12-step facilitation
- Vaping not permitted
- Mental health services
- Transportation assistance
- Social skills development
- Suicide prevention services
- Other contracted prescribing entity
- In-network prescribing entity
- Family counseling
- Substance use disorder education
- Smoking/vaping/tobacco cessation counseling
- Group counseling
- Self-help groups
- Housing services
- Discharge Planning
- Creole
- Prescribes naltrexone
- Buprenorphine detoxification
- Prescribes buprenorphine
- Accepts clients using MAT but prescribed elsewhere
- Psychiatric hospital
- This facility administers/prescribes medication for alcohol use disorder
- Adults
- Young Adults
- The Joint Commission
- State department of health
- State mental health department
- Hospital licensing authority
- State Substance use treatment agency
- Hospital inpatient/24-hour hospital inpatient
- Intensive outpatient treatment
- Outpatient
- Hospital inpatient detoxification
- Outpatient day treatment or partial hospitalization
- Hospital inpatient treatment
- In-network prescribing entity
- Other contracted prescribing entity
- Breathalyzer or blood alcohol testing
- Drug or alcohol urine screening
- TB screening
- Smoking permitted in designated area
- Acamprosate (CampralĀ®)
- Nicotine replacement
- Buprenorphine with naloxone
- Disulfiram
- Lofexidine
- Buprenorphine without naloxone
- Non-nicotine smoking/tobacco cessation
- Medication for mental disorders
- Clonidine
- Naltrexone (oral)
- Naltrexone (extended-release, injectable)
- Screening for mental disorders
- Outreach to persons in the community
- Comprehensive mental health assessment
- Comprehensive substance use assessment
- Screening for substance use
- Screening for tobacco use
- Spanish
- Sign language services for the deaf and hard of hearing
- Other languages (excluding Spanish)
- Hepatitis A (HAV) vaccination
- Hepatitis B (HBV) vaccination
Facility Operation (e.g., Private, Public)
Gender Accepted
Detoxification (medical withdrawal) Services
Opioid Medications used in Treatment
Special Programs/Groups Offered
Type of Care
Payment/Insurance/Funding Accepted
Treatment Approaches
Facility Vaping Policy
Ancillary Services
External Opioid Medications Source
Education and Counseling Services
Recovery Support Services
Transitional Services
Other Languages
Type of Opioid Treatment
Hospitals
Type of Alcohol Use Disorder Treatment
Age Groups Accepted
License/Certification/Accreditation
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
External Source of Medications Used for Alcohol Use Disorder Treatment
Testing
Facility Smoking Policy
Pharmacotherapies
Assessment/Pre-treatment
Language Services
Medical Services